CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C. Watt, Shom Goel, Paloma Cejas et al.|Nature Cancer|2020Cited by 110
Heterogeneity and transcriptional drivers of triple-negative breast cancerBojana Jovanović, Kornélia Polyák, Anne Fassl et al.|Cell Reports|2023Cited by 29